Driving innovation that truly revolutionizes sectors is a team effort. That’s exactly what Acto Co-Founder and CTO Kumar Erramilli is looking to do in the realm of biopharma, and he’s working with the team here at Boast to maximize his innovation potential and build one of the fastest-growing startups in all of Canada in the process.
ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact.
With ACTO, biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness.
While all of this is impressive on its own, Kumar has a wealth of experience across the North American tech ecosystem, having played a role in numerous startups and tech-centric organizations in his career to date. He’s a passionate inventor of AI and software technologies that are looking to change the way Life Sciences industry consumes technology, and I can’t wait to pick his brain on what’s in store for Acto and his take on the state of startups in 2024.
Where the rubber meets the road in SR&ED claim prep
Boast leverages the same information to build a successful R&D tax credits via our AI-driven platform integrations that our customers’ own product development teams are using to bring innovation to life.
Kumar Erramilli and the team at Acto share that ethos, as they’re also trying to bring various stakeholders—in their case biopharma and life sciences professionals—onto the same page by bringing accurate and actionable data for the fore.
Canada’s role in driving global innovation
Kumar and the team at Acto are creating innovation that’s helping put Canada on the global stage when it comes to driving game-changing technology breakthroughs.
Boast is proud to partner with Kumar and the community of innovators who are helping revolutionize the biopharma space and ultimately improve global well being.
As companies enter the growth stage of their startup lifecycle, they need to brace themselves when their success starts to plateau.
Every stage of growth calls for a different way to scale that’s going to push teams out of their comfort zone. It also means making sure that you don’t take the gas off of driving innovation even after you’ve achieved early success.
Check out the full interview with Kumar on Boast’s YouTube page here.
To learn more about how Boast can help you maximize innovation and access to capital, talk to an expert on our team today.
